STELARA® Phase 3 UNIFI Study - Ulcerative Colitis
Автор: HPR
Загружено: 2020-11-18
Просмотров: 1048
Описание:
Returning guest, Dr. William Sandborn, Chief of the Division of Gastroenterology at UC San Diego Health, discusses recent data from the Phase 3 UNIFI study evaluating the safety and efficacy of Janssen's STELARA® (ustekinumab) as a maintenance therapy in patients with moderately to severely active ulcerative colitis who previously failed biologic or conventional therapy. The long-term extension study out to two years, includes an abstract showing the effect of treatment on stool frequency and rectal bleeding. These data were presented at the 2020 American College of Gastroenterology (ACG) Annual Meeting.
#STELARA #Ustekinumab #UlcerativeColitis
Visit our website
www.healtprofessionalradio.com.au
Follow us on our social media channels
Facebook: / hprfm
Twitter: / healthproradio
Google+: https://plus.google.com/+HealthProfes...
Pinterest: / healthprora. .
Linkedin: / heal. .
Instagram: / healthprofe. .
Subscribe to our podcast channels
Soundcloud: / healthprofessi. .
Itunes: https://itunes.apple.com/nz/podcast/h...
Support us on Patreon
/ hpr
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
